AstraZeneca, a British-Swedish pharmaceutical and biotechnology giant, has deeply ingrained data science and AI capabilities throughout its drug development lifecycle. The company has implemented rigorous processes to ensure responsible development and deployment of AI solutions and is currently hiring two machine learning engineers in its data science division. AstraZeneca is also utilizing generative AI for research assistance, executive reporting, and competitive intelligence.
